I’m on Crowley ‘s side, of course. But I am left wondering whether he is, in fact, an “heir to a pharmaceutical fortune.”
Share this story
About the Author
Ramesh Ponnuru is the editor of National Review, a columnist for the Washington Post, and a fellow at the American Enterprise Institute.
Advertisement
Advertisement
Comments